170 related articles for article (PubMed ID: 35927674)
1. Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8).
Attar A; Monabati A; Montaseri M; Vosough M; Hosseini SA; Kojouri J; Abdi-Ardekani A; Izadpanah P; Azarpira N; Pouladfar G; Ramzi M
Trials; 2022 Aug; 23(1):632. PubMed ID: 35927674
[TBL] [Abstract][Full Text] [Related]
2. Single vs. double intracoronary injection of mesenchymal stromal cell after acute myocardial infarction: the study protocol from a randomized clinical trial: BOOSTER-TAHA7 trial.
Attar A; Nouri F; Yazdanshenas A; Hessami K; Vosough M; Abdi-Ardekani A; Izadpanah P; Ramzi M; Kojouri J; Pouladfar G; Monabati A
Trials; 2022 Apr; 23(1):293. PubMed ID: 35413932
[TBL] [Abstract][Full Text] [Related]
3. Effect of once versus twice intracoronary injection of allogeneic-derived mesenchymal stromal cells after acute myocardial infarction: BOOSTER-TAHA7 randomized clinical trial.
Attar A; Farjoud Kouhanjani M; Hessami K; Vosough M; Kojuri J; Ramzi M; Hosseini SA; Faghih M; Monabati A
Stem Cell Res Ther; 2023 Sep; 14(1):264. PubMed ID: 37740221
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Mesenchymal Stem Cell Therapy in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Yu J; Zhang RF; Mao YL; Zhang H
Curr Stem Cell Res Ther; 2022; 17(8):793-807. PubMed ID: 34397334
[TBL] [Abstract][Full Text] [Related]
5. A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction.
Lee JW; Lee SH; Youn YJ; Ahn MS; Kim JY; Yoo BS; Yoon J; Kwon W; Hong IS; Lee K; Kwan J; Park KS; Choi D; Jang YS; Hong MK
J Korean Med Sci; 2014 Jan; 29(1):23-31. PubMed ID: 24431901
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial.
Gao LR; Chen Y; Zhang NK; Yang XL; Liu HL; Wang ZG; Yan XY; Wang Y; Zhu ZM; Li TC; Wang LH; Chen HY; Chen YD; Huang CL; Qu P; Yao C; Wang B; Chen GH; Wang ZM; Xu ZY; Bai J; Lu D; Shen YH; Guo F; Liu MY; Yang Y; Ding YC; Yang Y; Tian HT; Ding QA; Li LN; Yang XC; Hu X
BMC Med; 2015 Jul; 13():162. PubMed ID: 26162993
[TBL] [Abstract][Full Text] [Related]
7. Preventive Effect of Bone Marrow Mononuclear Cell Transplantation on Acute Myocardial Infarction-Induced Heart Failure: A Meta-analysis of Randomized Controlled Trials.
Hosseinpour A; Hosseinpour H; Attar A
Cardiovasc Drugs Ther; 2023 Dec; 37(6):1143-1153. PubMed ID: 35876933
[TBL] [Abstract][Full Text] [Related]
8. Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.
Zhang W; Liu XC; Yang L; Zhu DL; Zhang YD; Chen Y; Zhang HY
Coron Artery Dis; 2013 Nov; 24(7):549-58. PubMed ID: 23892469
[TBL] [Abstract][Full Text] [Related]
9. Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials.
Xu JY; Liu D; Zhong Y; Huang RC
Stem Cell Res Ther; 2017 Oct; 8(1):231. PubMed ID: 29037256
[TBL] [Abstract][Full Text] [Related]
10. Effect of intracoronary bone marrow-derived mononuclear cell injection early and late after myocardial infarction on CMR-derived myocardial strain.
Gastl M; Sürder D; Corti R; Faruque Osmany DMM; Gotschy A; von Spizcak J; Sokolska J; Metzen D; Alkadhi H; Ruschitzka F; Kozerke S; Manka R
Int J Cardiol; 2020 Jul; 310():108-115. PubMed ID: 31982162
[TBL] [Abstract][Full Text] [Related]
11. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
12. Improvement in Left Ventricular Function with Intracoronary Mesenchymal Stem Cell Therapy in a Patient with Anterior Wall ST-Segment Elevation Myocardial Infarction.
Kim SH; Cho JH; Lee YH; Lee JH; Kim SS; Kim MY; Lee MG; Kang WY; Lee KS; Ahn YK; Jeong MH; Kim HS
Cardiovasc Drugs Ther; 2018 Aug; 32(4):329-338. PubMed ID: 29956042
[TBL] [Abstract][Full Text] [Related]
13. LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.
Traverse JH; Henry TD; Vaughan DE; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Simpson LM; Penn MS; Byrne BJ; Perin EC; Gee AP; Hatzopoulos AK; McKenna DH; Forder JR; Taylor DA; Cogle CR; Baraniuk S; Olson RE; Jorgenson BC; Sayre SL; Vojvodic RW; Gordon DJ; Skarlatos SI; Moyè LA; Simari RD;
Tex Heart Inst J; 2010; 37(4):412-20. PubMed ID: 20844613
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell transplantation after acute myocardial infarction: a meta-analysis of clinical trials.
Attar A; Bahmanzadegan Jahromi F; Kavousi S; Monabati A; Kazemi A
Stem Cell Res Ther; 2021 Dec; 12(1):600. PubMed ID: 34876213
[TBL] [Abstract][Full Text] [Related]
15. Comparing the effect of bone marrow mono-nuclear cells with mesenchymal stem cells after acute myocardial infarction on improvement of left ventricular function: a meta-analysis of clinical trials.
Hosseinpour A; Kheshti F; Kazemi A; Attar A
Stem Cell Res Ther; 2022 May; 13(1):203. PubMed ID: 35578329
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow mesenchymal stem cells transfer in patients with ST-segment elevation myocardial infarction: single-blind, multicenter, randomized controlled trial.
Zhang R; Yu J; Zhang N; Li W; Wang J; Cai G; Chen Y; Yang Y; Liu Z
Stem Cell Res Ther; 2021 Jan; 12(1):33. PubMed ID: 33413636
[TBL] [Abstract][Full Text] [Related]
17. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
[TBL] [Abstract][Full Text] [Related]
18. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit
Bolli R; Hare JM; March KL; Pepine CJ; Willerson JT; Perin EC; Yang PC; Henry TD; Traverse JH; Mitrani RD; Khan A; Hernandez-Schulman I; Taylor DA; DiFede DL; Lima JAC; Chugh A; Loughran J; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Moyé L; Ebert RF; Simari RD;
Circ Res; 2018 Jun; 122(12):1703-1715. PubMed ID: 29703749
[TBL] [Abstract][Full Text] [Related]
19. Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial.
Kristensen AMD; Bovin A; Zwisler AD; Cerquira C; Torp-Pedersen C; Bøtker HE; Gustafsson I; Veien KT; Thomsen KK; Olsen MH; Larsen ML; Nielsen OW; Hildebrandt P; Foghmar S; Jensen SE; Lange T; Sehested T; Jernberg T; Atar D; Ibanez B; Prescott E
Trials; 2020 May; 21(1):415. PubMed ID: 32446298
[TBL] [Abstract][Full Text] [Related]
20. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial.
Mathur A; Arnold R; Assmus B; Bartunek J; Belmans A; Bönig H; Crea F; Dimmeler S; Dowlut S; Fernández-Avilés F; Galiñanes M; Garcia-Dorado D; Hartikainen J; Hill J; Hogardt-Noll A; Homsy C; Janssens S; Kala P; Kastrup J; Martin J; Menasche P; Miklik R; Mozid A; San Román JA; Sanz-Ruiz R; Tendera M; Wojakowski W; Ylä-Herttuala S; Zeiher A
Eur J Heart Fail; 2017 Nov; 19(11):1545-1550. PubMed ID: 28948706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
